These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 10851499

  • 1. Significance of cytotoxic activity of peripheral blood lymphocytes against autologous tumor cells in patients with bladder cancer.
    Mizutani Y, Okada Y, Yoshida O, Bonavida B.
    Cancer Biother Radiopharm; 1996 Dec; 11(6):385-91. PubMed ID: 10851499
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y, Okada Y, Terachi T, Yoshida O.
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [Abstract] [Full Text] [Related]

  • 3. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y, Yoshida O, Bonavida B.
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [Abstract] [Full Text] [Related]

  • 4. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
    Mizutani Y, Yoshida O.
    J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunocompetence of tissue infiltrating lymphocytes in bladder tumors.
    Tsujihashi H, Matsuda H, Uejima S, Akiyama T, Kurita T.
    J Urol; 1988 Oct; 140(4):890-4. PubMed ID: 3262173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes.
    Mizutani Y, Yoshida O, Miki T.
    J Urol; 1999 Dec; 162(6):2170-5. PubMed ID: 10569614
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antitumor killer lymphocytes in the peripheral blood of a patient with transitional cell carcinoma of the bladder.
    Kim CJ, Yuasa T, Kushima R, Tomoyoshi T, Seto A.
    Int J Urol; 1998 May; 5(3):230-6. PubMed ID: 9624553
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.
    Vose BM, Gallagher P, Moore M, Schofield PF.
    Br J Cancer; 1981 Dec; 44(6):846-55. PubMed ID: 6976792
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.